Clinical trial

A Study of the Safety and Effectiveness of Levofloxacin Compared With…

NCT00258102 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed

Key facts

NCT number NCT00258102
Title A Study of the Safety and Effectiveness of Levofloxacin Compared With Lomefloxacin in the Treatment of Complicated Urinary Tract Infections
Official title A Multicenter, Randomized Study To Compare The Safety And Efficacy Of Oral Levofloxacin With That Of Lomefloxacin HCl In The Treatment Of Complicated Urinary Tract Infections In Adults
Lead sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry
Collaborators PriCara, Unit of Ortho-McNeil, Inc. Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Urinary Tract Infections, Bacterial Infections, Bacteriuria, Urologic Diseases
Intervention type Drug
Interventions Levofloxacin
Enrollment 603
Start date Jan 1, 1993
Completion Jan 1, 1995
First posted Nov 24, 2005
Last update posted Jun 10, 2011

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies